CDC801 is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of complex pharmaceutical compounds, particularly those targeting specific biological pathways. Its application is significant in the production of small molecule inhibitors that modulate enzyme activity, making it valuable in the treatment of diseases such as cancer and autoimmune disorders. Researchers also employ CDC801 in the development of novel therapeutic agents due to its ability to interact with cellular receptors, enhancing drug efficacy and specificity. Additionally, it is used in preclinical studies to evaluate pharmacokinetics and pharmacodynamics, aiding in the optimization of drug candidates for clinical trials.